Generic antiretroviral drugs--will they be the answer to HIV in the developing world?

Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial. BMJ (2011) 2.90

The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective study. BMJ (2010) 1.71

Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study. Int J Epidemiol (2012) 1.50

Financial burden of health services for people with HIV/AIDS in India. Indian J Med Res (2007) 1.09

Impact of highly active antiretroviral therapy on ophthalmic manifestations in human immunodeficiency virus / acquired immune deficiency syndrome. Indian J Ophthalmol (2008) 0.96

The association of adherence to antiretroviral therapy with healthcare utilization and costs for medical care. Appl Health Econ Health Policy (2008) 0.92

Long term impact of antiretroviral therapy--can we end HIV epidemic, the goal beyond 2015. Indian J Med Res (2014) 0.75

The perils of public health by press release. Lancet (2004) 0.75

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet (2004) 4.81